Re-examination of the CVMP's decision to phase out zinc oxide for young pigs
The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) will re-examine the decision to phase out medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs.
At its meeting on 6-8 December 2016, the CVMP decided to recommend to the European Commission that all medicinal products containing zinc oxide for young pigs should be withdrawn from the market.
Subsequently, the 18 marketing authorisation holders of veterinary medicinal products containing zinc oxide have requested a re-examination of the decision. According to Article 35 of the referral procedure, the marketing authorisation holders are entitled to request a re-examination in such cases.
This means that at its next meeting on 19 January 2017, the CVMP will appoint a new assessment team, which will review and re-examine the original documentation material as well as any additional or new material.
The procedure is expected to take around four months; consequently, the final decision of the Standing Committee on Veterinary Medicinal Products will be postponed.